Thank you very much, Madam Chair.
Thanks to the witnesses who are with us this afternoon.
When it comes to studying a bill in committee, it's always important to hear the views of experts. This bill will be quite broad in scope. Amendments need to be made to this act, which dates back a number of years.
Mr. Schwarcz, you said in your presentation that we shouldn't raise needless fears among citizens, and I believe you're right. In your view, if a product contains recognized carcinogens, it should be withdrawn from the market rather than be labelled with a warning. I understand your explanation very clearly. I remember that one witness said at a previous committee meeting that, under some legislation, the labelling of products containing carcinogens had been amended.
Do you think we should have avoided putting these kinds of warnings on those products in view of the fact that consumers suffered injury, whereas no serious evidence had been brought of the actual dangerousness of the substances in question?